India may extend duty exemptions on pharma inputs beyond June 30

The government has also sharpened the focus on diversification of markets to ensure the continued growth of pharma exports, which in FY2026 touched a little over $31 billionThe government has also sharpened the focus on diversification of markets to ensure the continued growth of pharma exports, which in FY2026 touched a little over $31 billion https://www.thehindu.com/business/india-may-extend-duty-exemptions-on-pharma-inputs-beyond-june-30/article71082194.ece 2026-06-10T06:50:49.000Z Business {}